Is Abraxas Petroleum (AXAS) Stock a Buy after Stephen Wendel’s Insider Deal?; Shorts at Jazz Pharmaceuticals Plc – Ordinary Shares (JAZZ) Lowered By 9.47%

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Logo

Jazz Pharmaceuticals Plc – Ordinary Shares (NASDAQ:JAZZ) had a decrease of 9.47% in short interest. JAZZ’s SI was 1.93 million shares in April as released by FINRA. Its down 9.47% from 2.13 million shares previously. With 447,200 avg volume, 4 days are for Jazz Pharmaceuticals Plc – Ordinary Shares (NASDAQ:JAZZ)’s short sellers to cover JAZZ’s short positions. The SI to Jazz Pharmaceuticals Plc – Ordinary Shares’s float is 3.3%. The stock increased 1.87% or $2.76 during the last trading session, reaching $150.18. About 375,512 shares traded. Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has declined 0.32% since April 5, 2017 and is downtrending. It has underperformed by 11.87% the S&P500.

Investors sentiment decreased to 1.25 in 2017 Q4. Its down 0.45, from 1.7 in 2017Q3. It fall, as 10 investors sold Abraxas Petroleum Corporation shares while 45 reduced holdings. 35 funds opened positions while 34 raised stakes. 81.39 million shares or 13.27% more from 71.85 million shares in 2017Q3 were reported. State Street accumulated 2.51 million shares. Schwab Charles Invest Management Incorporated accumulated 630,954 shares. Globeflex Ltd Partnership invested in 0.05% or 67,989 shares. Northern Tru has 0% invested in Abraxas Petroleum Corporation (NASDAQ:AXAS) for 2.10M shares. Captrust Financial holds 6,000 shares or 0% of its portfolio. Federated Investors Inc Pa holds 0% or 10,785 shares. Tudor Inv Corporation Et Al invested in 0% or 11,149 shares. Balyasny Asset Mgmt Ltd Liability Company accumulated 0% or 74,464 shares. Art Advsr Limited Co has invested 0.01% in Abraxas Petroleum Corporation (NASDAQ:AXAS). Stratos Wealth Ltd has 1,000 shares for 0% of their portfolio. King Luther Cap Mgmt Corp accumulated 15,809 shares or 0% of the stock. Teachers Insur Annuity Association Of America reported 367,314 shares stake. Tiaa Cref Investment Management Limited Liability Co stated it has 0% of its portfolio in Abraxas Petroleum Corporation (NASDAQ:AXAS). 20,000 were reported by Rothschild Il. California Pub Employees Retirement Sys invested 0% in Abraxas Petroleum Corporation (NASDAQ:AXAS).

Abraxas Petroleum Corporation, an independent energy company, engages in the acquisition, exploration, exploitation, development, and production of gas and oil properties in the United States. The company has market cap of $360.06 million. The firm operates gas and oil assets in the Permian/Delaware Basin, the Rocky Mountain, and South Texas regions. It has a 22.12 P/E ratio. As of December 31, 2017, its estimated net proved reserves were 65.4 million barrels of oil equivalent.

Among 11 analysts covering Abraxas Petroleum (NASDAQ:AXAS), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. Abraxas Petroleum has $4 highest and $1 lowest target. $2.70’s average target is 23.29% above currents $2.19 stock price. Abraxas Petroleum had 36 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, December 19 by Robert W. Baird. The stock of Abraxas Petroleum Corporation (NASDAQ:AXAS) has “Buy” rating given on Thursday, July 13 by Stifel Nicolaus. Rodman & Renshaw initiated Abraxas Petroleum Corporation (NASDAQ:AXAS) on Friday, October 21 with “Buy” rating. Canaccord Genuity maintained it with “Buy” rating and $3.0 target in Monday, January 8 report. The stock of Abraxas Petroleum Corporation (NASDAQ:AXAS) earned “Buy” rating by Canaccord Genuity on Monday, October 23. The firm earned “In-Line” rating on Friday, September 11 by Imperial Capital. Seaport Global downgraded the shares of AXAS in report on Wednesday, June 21 to “Neutral” rating. The firm has “Buy” rating by Seaport Global given on Friday, August 11. Canaccord Genuity maintained Abraxas Petroleum Corporation (NASDAQ:AXAS) on Tuesday, March 13 with “Buy” rating. The rating was maintained by Stifel Nicolaus with “Buy” on Monday, January 29.

The stock increased 0.46% or $0.01 during the last trading session, reaching $2.19. About 718,927 shares traded. Abraxas Petroleum Corporation (NASDAQ:AXAS) has risen 11.92% since April 5, 2017 and is uptrending. It has outperformed by 0.37% the S&P500.

7,149 shares of Abraxas Petroleum Corp were bought by Stephen Wendel, the corporation’s VP – Contracts and Marketing. Stephen Wendel’s shares are valued at precisely $15,728 which has been calculated on the basis of the average transactions stock price ($2.2 for every share). Right now, Stephen Wendel owns a total of 457,798 shares or 0.28% of the Company’s total market capitalization.

Among 22 analysts covering Jazz Pharmaceuticals (NASDAQ:JAZZ), 18 have Buy rating, 0 Sell and 4 Hold. Therefore 82% are positive. Jazz Pharmaceuticals had 78 analyst reports since August 3, 2015 according to SRatingsIntel. As per Tuesday, January 2, the company rating was maintained by Stifel Nicolaus. The company was maintained on Wednesday, February 24 by Mizuho. The company was maintained on Tuesday, August 8 by Piper Jaffray. The stock of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has “Hold” rating given on Thursday, August 31 by Mizuho. As per Tuesday, January 30, the company rating was maintained by Piper Jaffray. The firm earned “Neutral” rating on Thursday, April 6 by Mizuho. The firm has “Buy” rating by Cantor Fitzgerald given on Thursday, July 27. Goldman Sachs initiated Jazz Pharmaceuticals plc (NASDAQ:JAZZ) rating on Monday, June 6. Goldman Sachs has “Buy” rating and $196 target. Leerink Swann initiated Jazz Pharmaceuticals plc (NASDAQ:JAZZ) on Tuesday, January 2 with “Buy” rating. The firm has “Hold” rating by H.C. Wainwright given on Friday, August 25.

Investors sentiment increased to 1.09 in Q4 2017. Its up 0.06, from 1.03 in 2017Q3. It increased, as 30 investors sold Jazz Pharmaceuticals plc shares while 89 reduced holdings. 49 funds opened positions while 81 raised stakes. 52.98 million shares or 1.12% less from 53.58 million shares in 2017Q3 were reported. Mckinley Management Llc Delaware owns 477 shares for 0% of their portfolio. Bingham Osborn & Scarborough Limited Liability Company holds 0.19% of its portfolio in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) for 15,412 shares. Raymond James Svcs Advsr reported 5,904 shares stake. Brandywine Global Investment Mgmt Limited accumulated 209,076 shares. Cwm Ltd Liability Company invested in 119 shares or 0% of the stock. Renaissance invested 0.18% of its portfolio in Jazz Pharmaceuticals plc (NASDAQ:JAZZ). State Board Of Administration Of Florida Retirement reported 3,731 shares stake. Pub Employees Retirement Association Of Colorado reported 0.02% of its portfolio in Jazz Pharmaceuticals plc (NASDAQ:JAZZ). 1,341 were reported by Panagora Asset. Advisory Svcs Ltd Co accumulated 200 shares. Ranger Inv Management L P stated it has 2,134 shares or 0.02% of all its holdings. Gargoyle Invest Advisor Ltd Liability Com holds 3,623 shares. Bartlett & Ltd Com reported 0% in Jazz Pharmaceuticals plc (NASDAQ:JAZZ). Manufacturers Life The holds 0% or 383 shares in its portfolio. Fifth Third National Bank & Trust stated it has 0% in Jazz Pharmaceuticals plc (NASDAQ:JAZZ).

Abraxas Petroleum Corporation (NASDAQ:AXAS) Institutional Positions Chart